波多野结衣办公室双飞_制服 丝袜 综合 日韩 欧美_网站永久看片免费_欧美一级片在线免费观看_免费视频91蜜桃_精产国品一区二区三区_97超碰免费在线观看_欧美做受喷浆在线观看_国产熟妇搡bbbb搡bbbb_麻豆精品国产传媒

Global EditionASIA 中文雙語(yǔ)Fran?ais
World
Home / World / World Watch

A vaccine for all nations should be global focus

By Alfred Romann | China Daily Global | Updated: 2020-11-04 09:11
Share
Share - WeChat
A woman holds a small bottle labeled with a "Coronavirus COVID-19 Vaccine" sticker and a medical syringe in this illustration taken Oct 30, 2020. [Photo/Agencies]

The push to find a vaccine against COVID-19 is often depicted as a race between companies, or between countries, or even between science and a virus, or between biotechnology and immunity.

This idea of a race with winners and losers may be a handy metaphor, but it may also be counterproductive. In any race, there is one winner and a whole bunch of losers. Follow that train of thought and the result is a winner with a population protected against COVID-19 and a whole bunch of losers that are left to dangle in the wind.

This idea of the race is embodied in the visible trend of vaccine nationalism, which has led countries to commit hundreds of billions of dollars on vaccines that have not even been developed yet. They are spending that money to secure doses of vaccines for their own populations first.

This, according to the World Health Organization, could slow down the effort to come out on the other side of this pandemic as countries fend for themselveswith rich countries likely doing it better than poorer ones. Vaccine nationalism could slow down the global economic recovery and keep travel disruptions in place for much longer.

The only way to really do away with COVID-19 and return to normalcy-dining out, all children back in school, a resurgence in travel and tourism, the occasional party-may be through a coordinated and thought-out approach to vaccine distribution.

Effective multilateral efforts may be the only way for everyone to truly overcome COVID-19, not just those who can afford a vaccine or to dole out trillions of dollars in stimulus measures to shore up their economies.

There is a multinational effort underway to facilitate the global distribution of COVID-19 vaccines once they are available. The COVAX initiative is being led by the WHO and Gavi (the Vaccine Alliance), along with the Coalition for Epidemic Preparedness Innovations. Once vaccines become available, COVAX aims to purchase 2 billion doses for global distribution.

The goal of COVAX is to provide vaccines to 3 percent of the population of each member country that is most at risk and to share the costs of research and distribution between developed and developing countries.

China announced it had signed up to COVAX on Oct 8. It had earlier pledged its support and committed to setting affordable prices for vaccines developed in the country.

COVAX would also allow participating countries to buy enough vaccine to eventually cover as much as half of their populations. Few developed countries are buying that much from it, choosing instead to secure their own supplies, but many are using COVAX as something of an insurance for any overflow.

So far, 184 countries have signed up to COVAX.

The United States is the only major economy to say it will not join the effort. The administration of US President Donald Trump has said it will not be "constrained by multilateral organizations" influenced by the World Health Organization. In the global fight against COVID-19, it sometimes feels like it is the US versus the world.

At least four Chinese biotech companies are carrying out late-stage trials for their COVID-19 vaccines in countries around the world.

Sinovac, which is developing CoronaVac, is testing its vaccine in China and Brazil. The governor of Sao Paulo state told reporters on Oct 19 that CoronaVac is the safest of the various vaccines Brazil is testing.

Sinopharm, which is developing two vaccines, is also testing one in Brazil as well as in Bahrain and the United Arab Emirates. The company has reportedly agreed to carry out trials in Peru, Morocco and Pakistan.

CanSino Biologics is testing its vaccine in China and Saudi Arabia and has a partnership with Russia.

Along the same lines, China's BGI Genomics, the largest genetic testing company of its kind, is opening a plant in Ethiopia to provide COVID-19 tests in Africa.

Other global pharmaceutical companies, including Moderna, AstraZeneca and Johnson & Johnson, are testing vaccines in multiple places.

Even after the vaccines are approved, manufacturing and distribution will be a challenge. Testing a vaccine in multiple countries is one thing, and manufacturing in multiple places is quite another, while transportation and delivery also pose a challenge.

Not all countries have the facilities to manufacture vaccines or the infrastructure in place to distribute them-infrastructure such as effective cold chains to keep the vaccines in good condition and safe, and the ability to ensure that recipients get the expected two shots that most vaccines will likely require.

Vaccine nationalism has already emerged as a concern, even before trials are concluded. Rich nations have committed to buying huge numbers of doses. Poor nations, not so much. In Africa, for example, vaccines are only being tested in South Africa-the country is testing vaccines being developed by US company Novavax and the United Kingdom's Jenner Institute.

The desire to protect a domestic population first is understandable, but losing sight of the fact that the world is now, more than ever, globalized may be counterproductive.

Vaccine nationalism could both shape and slow down the global response to COVID-19.

Getting past the barriers created by the unilateral efforts of countries to secure vaccines for their own people first and prioritizing a coordinated global response will ultimately be the key to getting the entire world back to some kind of normalcy sooner rather than later.

The alternative, the one we are heading toward now, is a splotchy response that results in some countries opening up first and others, more likely the poorer ones, being left behind.

The writer is the managing director of Bahati Ltd, a Hong Kong-based editorial services consultancy. The views do not necessarily reflect those of China Daily.

Most Viewed in 24 Hours
Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
波多野结衣办公室双飞_制服 丝袜 综合 日韩 欧美_网站永久看片免费_欧美一级片在线免费观看_免费视频91蜜桃_精产国品一区二区三区_97超碰免费在线观看_欧美做受喷浆在线观看_国产熟妇搡bbbb搡bbbb_麻豆精品国产传媒
欧美系列亚洲系列| 蜜桃视频一区二区三区在线观看| 国产乱子伦视频一区二区三区| 最近中文字幕无免费| 欧美日产在线观看| 亚洲国产综合视频在线观看| 91亚洲精华国产精华精华液| 国精品无码一区二区三区| 欧美激情在线一区二区三区| 国产一区二区伦理片| 貂蝉被到爽流白浆在线观看| 国产午夜精品一区二区三区嫩草| 国内成人精品2018免费看| 91社区视频在线观看| 国产欧美一区在线| 风间由美中文字幕在线看视频国产欧美| 欧美成人短视频| 国产精品入口麻豆九色| aaa国产一区| 精品视频999| 水蜜桃久久夜色精品一区的特点 | 蜜臀av一区二区在线观看| 奇米777第四色| 日韩视频中午一区| 激情综合色综合久久| 免费成人深夜蜜桃视频| 国产精品理伦片| 91色porny在线视频| 欧美日韩一本到| 日韩中文字幕区一区有砖一区 | 亚洲另类在线一区| 岛国精品一区二区三区| 欧美一卡2卡3卡4卡| 黄色日韩网站视频| 色综合久久综合网欧美综合网 | 亚洲熟女一区二区三区| 91麻豆精品国产无毒不卡在线观看 | wwwww在线观看| 日韩一区二区三区视频在线观看| 麻豆精品国产91久久久久久| 最新中文字幕av| 中文字幕视频一区| 麻豆精品国产传媒av| 久久久久久**毛片大全| 99久久免费视频.com| 9191成人精品久久| 国产一本一道久久香蕉| 在线观看三级视频欧美| 蜜臀91精品一区二区三区| 91狠狠综合久久久| 亚洲不卡一区二区三区| 91国模少妇一区二区三区| 国产精品蜜臀在线观看| 国产一线在线观看| 国产欧美精品一区aⅴ影院| 91丨九色丨蝌蚪丨老版| 欧美不卡在线视频| 99精品欧美一区二区蜜桃免费| 日韩一级黄色大片| 波多野结衣在线一区| 91精品国产欧美一区二区| 国产精品2024| 91精品国产综合久久久久久| 风间由美中文字幕在线看视频国产欧美| 欧美日韩亚洲综合在线| 国产精品综合av一区二区国产馆| 欧美午夜一区二区三区免费大片| 韩国av一区二区三区| 欧美三级午夜理伦三级中视频| 久久精品国产亚洲aⅴ| 在线免费av一区| 国产一区在线精品| 欧美狂野另类xxxxoooo| 福利电影一区二区| 日韩美女一区二区三区| 日本少妇一区二区三区| 国产网站一区二区三区| 在线天堂www在线国语对白| 亚洲欧洲成人精品av97| 国产精品密蕾丝袜| 亚洲成人激情自拍| 色综合天天综合狠狠| 精品在线一区二区三区| 欧美精品日日鲁夜夜添| 成人动漫一区二区| 国产亚洲福利社区一区| 少妇精品无码一区二区三区| 日韩理论片在线| 四虎影视一区二区| 美腿丝袜亚洲色图| 欧美日本一区二区三区四区| www.亚洲免费av| 国产欧美视频一区二区三区| 一级性生活毛片| 亚洲动漫第一页| 日本高清无吗v一区| 国产福利一区二区三区| 亚洲精品在线网站| 超碰97在线资源站| 亚洲第四色夜色| 欧洲av一区二区嗯嗯嗯啊| 高潮精品一区videoshd| 久久亚洲精精品中文字幕早川悠里| 亚洲欧美日韩偷拍| 亚洲国产色一区| 好吊色视频在线观看| 国产麻豆精品在线观看| 精品99一区二区| 波多野结衣a v在线| 日精品一区二区三区| 91久久一区二区| av电影一区二区| 国产精品国产三级国产a| 日日操免费视频| 国产麻豆9l精品三级站| 国产亚洲一区二区三区| 成人激情五月天| 国模一区二区三区白浆| 精品精品国产高清一毛片一天堂| 青青草视频播放| 日本不卡123| 日韩亚洲欧美在线| 亚洲蜜桃精久久久久久久久久久久| 视频国产一区二区| 国产在线观看免费一区| 久久久国产精品午夜一区ai换脸| 青娱乐国产视频| 国产精品自拍一区| 欧美激情在线一区二区三区| 国产精品免费在线视频| 国产成人aaa| 国产精品成人在线观看| 色狠狠桃花综合| 97精品久久久午夜一区二区三区| 亚洲精品国产高清久久伦理二区| 欧美综合亚洲图片综合区| 91麻豆国产精品久久| 亚洲第一成年网| 欧美sm极限捆绑bd| 国产午夜精品福利视频| 国产成人亚洲精品狼色在线| 国产精品毛片a∨一区二区三区| 日本天堂中文字幕| 国模大尺度视频| 午夜精品123| 精品久久久久久久久久久久久久久久久| 亚洲国产天堂av| 国产精品66部| 亚洲免费在线电影| 欧美丰满一区二区免费视频| 国产精品jizz| 国产精品538一区二区在线| 1024成人网色www| 欧美日韩成人高清| 中文字幕免费高清| 成人美女在线观看| 亚洲午夜电影在线观看| 日韩精品中文字幕一区二区三区 | 中文字幕日韩三级片| 精品一区二区国语对白| 国产精品你懂的在线欣赏| 欧美色大人视频| 欧美一区二区三区成人精品| 国产一区二区美女| 一区二区三区毛片| 欧美videos大乳护士334| 搜索黄色一级片| 日韩女优在线视频| 韩国成人精品a∨在线观看| 亚洲婷婷国产精品电影人久久| 538在线一区二区精品国产| 欧洲美熟女乱又伦| 成人免费黄色在线| 五月婷婷欧美视频| 国产欧美日产一区| 欧美三电影在线| 亚洲一二三精品| 性一交一黄一片| 国产一区二区主播在线| 一区二区三区中文字幕| 精品剧情在线观看| 在线视频综合导航| 精品无码国产污污污免费网站 | 色94色欧美sute亚洲线路一久| 91视频啊啊啊| 成人中文字幕电影| 日韩av电影一区| 日韩一区日韩二区| 欧美mv日韩mv亚洲| 在线观看日韩一区| 亚洲女同二女同志奶水| 插我舔内射18免费视频| 福利电影一区二区三区| 日韩av一区二区三区| 亚洲婷婷综合久久一本伊一区| 日韩精品一区二区三区老鸭窝| 色中色一区二区| ass极品国模人体欣赏| 黄色免费视频网站| 99综合影院在线|